cyclic peptide inhibitors of lysine-specific demethylase 1 (Medical University of South Carolina)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecyclic peptide inhibitors of lysine-specific demethylase 1 (Medical University of South Carolina)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsFibrosisDiabetes MellitusHematologic Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedical University Of South Carolina
Active IndicationsN/A
Inactive IndicationsFibrosisDiabetes MellitusHematologic Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A